Dr Ing-Soo Tiong
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
67 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
DOI: 10.1182/blood.20250314802024
Research grants (ARC, NHMRC, MRFF)
ADAPT (Achieving Durable Remission via Adaptive Pro-Survival Targeting in Acute Myeloid Leukaemia)
2023
Journal article
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
DOI: 10.1182/blood.20220160902022
Journal article
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
DOI: 10.1182/bloodadvances.20220083252020
Journal article
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined with Modified Intensive Chemotherapy
DOI: 10.1200/JCO.20.005722020
Journal article
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
DOI: 10.1182/BLOOD.20190039882019
Journal article
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
DOI: 10.1038/s41375-018-0261-3
RECENT SCHOLARLY WORKS
2026
Journal article
Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets
DOI: 10.1038/s41375-026-02886-62026
Journal article
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy
DOI: 10.1182/bloodadvances.20250170832026
Journal article
Advancing diagnostic targeted RNA sequencing for haematological malignancies within an Australian sample exchange program
DOI: 10.1016/j.pathol.2025.09.0032026
Journal article
The telomeric puzzle inTP53-mutant myeloid neoplasms
DOI: 10.1182/blood.20250311242025
Journal article
Genomic variation in DDX41 identified through clinical sequencing
DOI: 10.1111/bjh.700862025
Journal article
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
DOI: 10.1182/bloodadvances.20250160632025
Journal article
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)
DOI: 10.1182/bloodadvances.20240149002025
Journal article
CAR T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
DOI: 10.1056/NEJMoa2309728